- Home
- TR vs APLS Comparison
TR vs APLS Comparison
Compare TR & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TR | APLS |
|---|---|---|
| Founded | 1896 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.7B |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | TR | APLS |
|---|---|---|
| Price | $37.46 | $23.73 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 19 |
| Target Price | N/A | ★ $33.11 |
| AVG Volume (30 Days) | 135.0K | ★ 2.4M |
| Earning Date | 10-23-2025 | 10-30-2025 |
| Dividend Yield | ★ 0.96% | N/A |
| EPS Growth | ★ 0.79 | N/A |
| EPS | ★ 1.28 | 0.36 |
| Revenue | $729,620,000.00 | ★ $1,016,397,000.00 |
| Revenue This Year | N/A | $29.00 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $29.26 | $65.98 |
| Revenue Growth | 0.34 | ★ 42.11 |
| 52 Week Low | $28.67 | $16.10 |
| 52 Week High | $44.27 | $35.72 |
Technical Indicators
Market Signals| Indicator | TR | APLS |
|---|---|---|
| Relative Strength Index (RSI) | 41.69 | 62.06 |
| Support Level | $37.21 | $20.51 |
| Resistance Level | $38.02 | $21.72 |
| Average True Range (ATR) | 0.98 | 0.81 |
| MACD | -0.08 | 0.51 |
| Stochastic Oscillator | 14.33 | 92.66 |
Price Performance
Historical ComparisonAbout TR Tootsie Roll Industries Inc.
Tootsie Roll Industries Inc manufactures and sells confectionery products. Notable varieties include Tootsie Roll and Tootsie Pops, Charms, Blow-Pops, Dots, Junior Mints, Sugar Daddy and Sugar Babies, Andes, Dubble Bubble, Razzles among others. The company sells its products to wholesale distributors and directly to retail stores. Geographically, it generates a majority of its revenue from the United States and rest from Canada, Mexico and other regions.
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.